Related Experiment Video
Updated: Apr 15, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Development of a modified yoga program for pulmonary hypertension: a case series
Modified yoga is a safe and effective approach for pulmonary hypertension (PH) patients, improving lifestyle behaviors and reducing anxiety and pain. This study highlights its potential as a complementary therapy for PH management.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Integrative Medicine
Background:
- Pulmonary hypertension (PH) is a severe condition with limited non-pharmacologic treatment options.
- Current medications improve outcomes but do not fully address patient quality of life.
- The impact of yoga and meditative breathing on PH remains largely unexplored.
Observation:
- A case series involving 3 patients with varying functional abilities in pulmonary arterial hypertension (PAH).
- Patients engaged with a modified yoga program delivered via DVD, YouTube, and a dedicated application.
- Participants self-reported observations and completed the Health Promoting Lifestyle Profile II (HPLPII) questionnaire over 8 weeks.
Findings:
- The modified yoga intervention was feasible, safe, and effective in the studied cases.
- Patients reported reduced anxiety and joint pain.
- Health-promoting behaviors, as measured by HPLPII, showed improvement across all participants.
- No adverse events were reported during the yoga practice.
Implications:
- Modified yoga offers a standardized and accessible therapeutic option for pulmonary hypertension patients.
- This approach warrants further investigation in larger-scale studies to confirm efficacy and safety.
- Yoga may serve as a valuable complementary therapy to conventional treatments for PH.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

